Skip to main content
Home
Search
Multi-scale Atlas
NEW
Search for Drug ADMET Endpoint Profile (DAE)
NEW
Search for Drug Pharmacogenomic Perturbation Map (DPP)
NEW
Search for Drug-Molecule Activity Atlas (DMA)
NEW
Drug Development Portfolio
Search for Drug
Search for Combinatorial Drug (CBD)
Search for Repurposed Drug (RPD)
Drug-interacting Molecule
Search for Drug Therapeutic Target (DTT)
Search for Drug Transporter (DTP)
Search for Drug-Metabolizing Enzyme (DME)
Search for Drug Off-target (DOT)
Disease
Search for Disease
Download
Help
About
Details of the Drug Formulaction
General Information of Drug Formulation (ID: F18925)
Formulation Name
Repaglinide 2 mg tablet
Company
Breckenridge Pharmaceutical; Golden State Medical Supply
Pharmaceutical Drug(s) in Formulation
Drug Name
Drug ID
Indication
ICD 11
Status
Repaglinide
DM5SXUV
Diabetic complication
5A2Y
Approved
--------------------
Pharmaceutical Excipient(s) in Formulation
Excipient Name
Excipient ID
PubChem CID
Functional Classification
Eisenoxyd
E00585
56841934
Colorant
Magnesium stearate
E00208
11177
lubricant
Poloxamer 407
E00646
Not Available
Emulsifying agent; Solubilizing agent; Surfactant
Vinylpyrrolidone
E00668
Not Available
Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent
--------------------